Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery.
Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery.
复制标题
用立体纯可电离脂质替代外消旋可电离脂质可以增加 mRNA 递送。
DOI:
10.1016/j.jconrel.2022.11.037
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Dahlman,JamesE
中科院分区:
文献类型:
--
作者:
DaSilvaSanchez,AlejandroJ;Zhao,Kun;Huayamares,SebastianG;Hatit,MarineZC;Lokugamage,MelissaP;Loughrey,David;Dobrowolski,Curtis;Wang,Shuaishuai;Kim,Hyejin;Paunovska,Kalina;Kuzminich,Yanina;Dahlman,JamesE
Lipid nanoparticles (LNPs) have delivered siRNA and mRNA drugs in humans, underscoring the potential impact of improving the therapeutic window of next-generation LNPs. To increase the LNP therapeutic window, we applied lessons from small-molecule chemistry to ionizable lipid design. Specifically, given that stereochemistry often influences small-molecule safety and pharmacokinetics, we hypothesized that the stereochemistry of lipids within an LNP would influence mRNA delivery. We tested this hypothesisin vivousing 128 novel LNPs that included stereopure derivatives of C12‐200, an ionizable lipid that when formulated into LNPs delivers RNA in mice and non-human primates but is not used clinically due to its poor tolerability. We found that a novel C12‐200-S LNP delivered up to 2.8-fold and 6.1-fold more mRNAin vivothan its racemic and C12‐200-R controls, respectively.To identify the potential causes leading to increased delivery, we quantified LNP biophysical traits and concluded that these did not change with stereochemistry. Instead, we found that stereopure LNPs were better tolerated than racemic LNPsin vivo. These data suggest that LNP-mediated mRNA delivery can be improved by designing LNPs to include stereopure ionizable lipids.